MedTrace Logo

Radiotherapy vs Observation for CRPC

NCT01590498 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2012-05-04

No results posted yet for this study

Summary

The purpose of the study is to determine whether radiotherapy improves cancer control and overall survival among patients with Castration resistant prostate cancer.

Conditions

  • Hormone Refractory Prostate Cancer

Sponsors & Collaborators

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • the cancer hospital of Zhengzhou University

    collaborator UNKNOWN

  • People's Hospital of Zhengzhou University

    collaborator OTHER

  • Xinyang Central Hospital

    collaborator OTHER

  • Zhoukou Central Hospital

    collaborator OTHER

  • the second people's hospital of kaifeng

    collaborator UNKNOWN

  • Zhengzhou University

    lead OTHER

Principal Investigators

  • Liu Bingqian, MD Ph.D · The First Affiliated Hospital of Zhengzhou University

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-12-31
Completion
2017-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01590498 on ClinicalTrials.gov